Currently, irrespective of your age or medical conditions, once the Physician or Practitioner diagnosed you with coronavirus/COVID-19, you are sent home primarily with an unspoken word, “only return when you about to die.” This new Pandemic standard of practice, embraced nationwide or worldwide to that matter, in physician-patient relationship is detrimental.Read more

The purpose of this blog is to alert and to inform you the reader and to suggest to the practitioners as well as the health authorities that there is undoubtedly a better way of isolating our patients, and more importantly there is a better way of preventing the inflammatory Tsunami from taking off.  There must be a better and safer lifesaving approach than our current model of going home to monitor yourself and “only return when you about to die.”Read more

The difference between life and death could be determined by timely recognition of these timelines and earliest possible interventions to prevent and treat the inflammatory and thrombotic Tsunamis. The obsessions so far have been to target the virus, but we must not ignore the collateral damages triggered by the infection, which is what leads to patient’s death.Read more

It is necessary then to understand what happens during incubation periods, and the different phases from the first day of symptoms through day 6,  stage 2 of day 7 to day ten and finally what happened beyond day ten what I called salvage and death stage, 3.Read more

During this phase, it is habitual to explain away your symptoms.  Let me illustrate it this way:Read more

Between the first-day to 6-day of symptoms, there is no much damage to your organs yet.  However, as you are approaching day seven, your immune system that has never seen this virus before panics, they respond in a very aggressive way from day one actually, what I call inflammatory Tsunami starts to build up. Read more

The CDC has informed of several study results, which showed, the COVID 19 virus cannot be cultured beyond day 9. Notable is that it is detectable through PCR, but to know whether it is alive, you have to culture and grow it. Only living things do grow, and dead things don’t. Read more

The following is food for thoughts for my colleagues in the healthcare professionals and the health authorities in general. If indeed the virus is nonviable after day 9, then it brings into questions any studies design with anti-replications agents in acute inpatient settings. It may be that the most successful battle against the virus is not in the inpatient but rather outpatient, no more true than in this virus “Prevention is better than cure” especially when there are none effective. In prevention here, I am referring to searching for ways to avoid getting into Phase 3 of the infection.Read more

This new data tells us we are currently perhaps running on the wrong paradigm; we have the wrong methodology.  If this data is correct and then hydroxychloroquine plus Zinc is of no use but also ultimately Remdesivir and any other anti-replication regimen beyond day 9. How about convalescent plasma, any virus to neutralized after day 10? Seems not, we likely missed the window here as well! Read more

How should we make use of the knowledge of the known high-risk group such as my unfortunate patient above, men older than 65, women more aged than 60, immunosuppressed, cancer patients, diabetics, morbidly obese, etc.?Read more

We are missing the windows of early life savings and meaningful interventions and playing catch and salvage therapies in the ward and ICU, the later with dismal results.Read more

 

Reference links:

01. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
02. Symptom-Based Strategy to Discontinue Isolation for Persons with COVID-19
03. Timeline of Symptoms of Severe Coronavirus Disease 2019 (Covid-19).
04. Megakaryocytesandplatelet-fibrinthrombicharacterizemulti-organthrombosisatautopsyinCOVID-19: A case series

 

Dr. George Philip Imuro, MD Is a board certified by the American Board of internal Medicine. He is a member of the American college of Physicians. A dedicated Hospitalist with Avera Medical group, chair of ICU committee. He additionally held the position of Hospitalist Director, mimbres Memorial Hospital. Dr Imuro is a Former employee of Department of defense with the US Army in Capacity as Academic Hospital in internal medicine and an appointed professor, with Texas Tech University. Dr Imuro completed Medical school at Universidad De Montemorelos, NL Mexico. He is a graduate of Texas Tech University Residency Program in Internal medicine. Awards: Dr Imuro, earned the Charles W Stark of Academic for excellencies for the highest GPA and 1st place in graduating class. Community work: Dr Imuro currently is the Senior Medical officer, South Sudanese Diaspora COVID task force, dedicated to a weekly educations and interaction with the diaspora communities.